Widecells' ground-breaking stem cell insurance platform goes live in the UK


Pioneer Founding member
Widecells' ground-breaking stem cell insurance platform goes live in the UK
21 Jul 2017


The online facility will initially be for customers of tissue bank Biovault, but in the upcoming weeks WideCells intends to make CellPlan available to families that have stored stem cells in other facilities that meet the appropriate standards.

These families will be able to purchase CellPlan directly via the e-commerce platform.

CellPlan enables individuals who have stored stem cells from umbilical cord blood to protect their families against future illness by covering the cost of any stem cell treatment.

The e-commerce platform includes a quote and buy system that allows customers to obtain a quote online, purchase CellPlan, and obtain all the relevant documentation. Requisite checks will also be handled by the platform.

Joao Andrade, Widecells’ chief executive, expects CellPlan to generate revenues almost immediately now that it is online.

"Our recent agreement with Biovault paved the way for initial sales and maiden revenues from CellPlan, and in launching this e-commerce platform our sales and financial progress can only increase.

“This platform enables families in the UK to purchase our innovative insurance product directly, thus enabling us to target a very large market with relatively minimal expenditure.

"This platform naturally has expansion potential beyond the UK."